key: cord-0807628-l0zj6v0u
authors: Bordt, Evan A; Shook, Lydia L; Atyeo, Caroline; Pullen, Krista M; De Guzman, Rose M; Meinsohn, Marie-Charlotte; Chauvin, Maeva; Fischinger, Stephanie; Yockey, Laura J.; James, Kaitlyn; Lima, Rosiane; Yonker, Lael M; Fasano, Alessio; Brigida, Sara; Bebell, Lisa M; Roberts, Drucilla J; Pépin, David; Huh, Jun R; Bilbo, Staci D; Li, Jonathan Z; Kaimal, Anjali; Schust, Danny; Gray, Kathryn J; Lauffenburger, Douglas; Alter, Galit; Edlow, Andrea G
title: Sexually dimorphic placental responses to maternal SARS-CoV-2 infection
date: 2021-03-29
journal: bioRxiv
DOI: 10.1101/2021.03.29.437516
sha: fabc04e2dc31c125df5cb880a8cfbcc2453a61c2
doc_id: 807628
cord_uid: l0zj6v0u

There is a persistent male bias in the prevalence and severity of COVID-19 disease. Underlying mechanisms accounting for this sex difference remain incompletely understood. Interferon responses have been implicated as a modulator of disease in adults, and play a key role in the placental anti-viral response. Moreover, the interferon response has been shown to alter Fc-receptor expression, and therefore may impact placental antibody transfer. Here we examined the intersection of viral-induced placental interferon responses, maternal-fetal antibody transfer, and fetal sex. Placental interferon stimulated genes (ISGs), Fc-receptor expression, and SARS-CoV-2 antibody transfer were interrogated in 68 pregnancies. Sexually dimorphic placental expression of ISGs, interleukin-10, and Fc receptors was observed following maternal SARS-CoV-2 infection, with upregulation in males. Reduced maternal SARS-CoV-2-specific antibody titers and impaired placental antibody transfer were noted in pregnancies with a male fetus. These results demonstrate fetal sex-specific maternal and placental adaptive and innate immune responses to SARS-CoV-2.

Mortality and morbidity risk during the perinatal period and infancy is significantly higher in males than in females (1) (2) (3) (4) . The underlying susceptibility of males may relate to evolutionary differences that occur throughout pregnancy and in the perinatal period, but the precise mechanistic differences that lead to this differential female survival benefit is not completely understood. Consistent with perinatal male vulnerability in general, male infants and children fare significantly worse in the setting of SARS-CoV-2 infection, with higher rates of severe disease in infants and multisystem inflammatory syndrome in children (MIS-C), a SARS-CoV-2 inflammatory syndrome associated with shock, cardiac involvement, and significantly elevated markers of inflammation (5) (6) (7) (8) (9) (10) . The biological basis for the observed relative vulnerability of the male immune system to SARS-CoV-2 in pediatric populations is likely multifactorial (11, 12) . Emerging data point to a retrograde impact of infant sex on maternal immunity (13, 14) , with specific differences in innate immune signaling across fetal sex, which may contribute to a differential dialogue between female and male fetuses with their mothers. This differential dialogue may critically impact immunity across the dyad, leading to an alternative hypothesis underlying sex-based differences in perinatal life, including the possibility of differential transfer of immunity from the mother that may empower female and male infants with differential levels of immunity.

Type I and Type III interferons (IFN) are induced after innate recognition of viruses. Upon binding to their receptors, they induce expression of downstream effectors, interferon stimulated genes (ISGs), which inhibit viral infection by a number of different mechanisms (15) . However, viruses have evolved to evade these IFN responses, and IFN responses can also be drivers of inflammatory pathology. Type I IFN signaling correlates strongly with pathogenicity and fatality in both SARS-CoV-1 and MERS-CoV infections (16) (17) (18) .

Dysregulated Type I IFN signaling is also associated with severe disease and drives pathogenicity in SARS-CoV-2 infection, in both humans and murine models (17, (19) (20) (21) (22) (23) (24) (25) . Notably, sex differences in adult peripheral blood and pulmonary IFN signaling have been observed in both SARS-CoV-1 and SARS-CoV-2 infection (26) (27) (28) , but there is a dearth of information about sex differences in fetal and pediatric populations. Type I and Type III IFN responses at the maternal-fetal interface play a crucial role in limiting viral infection but may also be drivers of abnormal development (29) (30) (31) . Sex differences have been noted in the placental immune response to bacterial infection (32, 33) and to other prenatal alterations such as maternal stress and maternal high-fat diet (12, 34, 35) . However, placental expression of interferon-stimulated genes (ISGs) in maternal SARS-CoV-2 infection, the role of sex differences, and potential impact on placental function have not yet been examined.

Newborn anti-viral immunity relies heavily on the placental transfer of maternal immunoglobulin-G (IgG) to the fetal circulation (36) (37) (38) . Public health strategies to protect newborns from potentially devastating respiratory infections such as pertussis and influenza capitalize on the ability of the placenta to transfer vaccineinduced maternal IgG to the fetal circulation (39, 40) . Fragment crystallizable (Fc) receptors in the placenta play an active role in antibody transfer from mother to fetus (36, 37, (41) (42) (43) . FCR1 expression relies on IFN, and emerging data have clearly demonstrated perturbed placental transfer in the setting of other coinfections including HIV (44) and malaria (45) . Whether differences in inflammatory responses to SARS-CoV-2 infection could influence placental antibody transfer is unknown. In addition, little is known regarding sex differences in neonatal immune profiles and in maternal-fetal antibody transfer. Recent work has demonstrated reduced transplacental transfer of SARS-CoV-2-specific antibodies relative to influenza and pertussis antibodies (46, 47) , and associated alterations in expression and localization of specific Fc receptors in the placenta (47) , but sex differences in neonatal antibody-mediated immunity to SARS-CoV-2 and in placental receptors involved in antibody transfer have not yet been characterized.

Given known sex differences in immune responses to SARS-CoV-2 infection (26) , the observed sex differences in disease prevalence and severity in the pediatric population including infants (6) (7) (8) (9) , and the placenta's critical role as an immune organ mediating anti-viral responses and antibody transfer at the maternalfetal interface (31) , we sought to examine sex differences in the placental immune response to SARS-CoV-2 and how this may impact placental expression of receptors associated with antibody transfer. In a cohort of 38 participants infected with SARS-CoV-2 during pregnancy (19 male and 19 female fetuses) and a comparator group of 30 contemporaneously-enrolled pregnant women testing negative for SARS-CoV-2 (15 male and 15 female fetuses), striking differences were noted in placental transfer of antibodies to male and female infants linked to different ISG-driven Fc-receptor expression profiles in the placenta. These data point to unexpected sex-driven bilateral communication across the maternal:fetal interface associated with differences in rates of antibody transfer to SARS-CoV-2 that may help explain a major unaddressed sex-based difference across infectious diseases in male infants globally.

Maternal demographic and clinical characteristics of study participants for placental analyses grouped by offspring sex are depicted in Table 1 , while those providing maternal and umbilical cord blood are depicted in Supplementary Table 1 . Of the 68 participants, 34 were pregnant with females and 34 with males. There were no significant differences between groups with respect to maternal age, parity, obesity, diabetes, hypertension, or gestational age at delivery, among other characteristics examined. Women with SARS-CoV-2 infection during pregnancy were more likely to be Hispanic compared to negative controls, concordant with our prior report of ethnic disparities in COVID-19 vulnerability in our hospital catchment area (48) . Of the 38 women with SARS-CoV-2 infection during pregnancy, there were no significant differences between male and female fetuses with respect to gestational age at diagnosis of SARS-CoV-2 infection, days from positive SARS-CoV-2 test to delivery, or severity of COVID-19 illness. Although both male and female fetuses of mothers with SARS-CoV-2 had lower birthweights than their sex-matched control counterparts, clinically this difference was not meaningful as all neonatal birthweights were in the normal range. No neonates born to mothers with SARS-CoV-2 infection during pregnancy were infected with SARS-CoV-2. [30] [31] [32] [33] [34] [35] [36] 34 [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] 30 [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 31 [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] 0.34 

Placental inflammation is associated with impaired antibody transfer (45, 55) , and reduced transplacental antibody transfer has been shown in the context of maternal infections such as HIV (44) and malaria (45) . Given the known vulnerability of male infants to more severe respiratory disease (11), we sought to determine whether the sex of the fetus would impact transplacental transfer of maternal SARS-CoV-2specific antibodies. We comprehensively profiled SARS-CoV-2 antibodies spike (S), receptor binding domain (RBD), spike S1 subunit (S1), spike S2 subunit (S2), and nucleocapsid (N) including titer, function, and placental receptor interactions in maternal:cord plasma pairs of SARS-CoV-2 exposed and unexposed (SARS-CoV-2 negative) pregnancies, using a previously-described Systems Serology approach (47) . Rather than the expected transplacental transfer observed for other pathogens (cord-to-maternal ratio of 1.1-1.5 or greater (42, 56, 57) ), IgG titers against all examined SARS-CoV-2 antigens were significantly reduced in cord relative to maternal plasma across IgG subtypes in pregnancies with a male fetus compared to those with a female fetus ( Fig. 2A , Supplementary Fig. 2 ). In contrast, significant reduction in cord versus maternal titers was only observed in the case of N-specific IgG2 in pregnancies with a female fetus ( Supplementary Fig. 2 ). There were significantly reduced cord:maternal transfer ratios for SARS-CoV-2-specific antibodies in male versus female fetuses (Fig. 2B) , and significantly reduced transfer of SARS-CoV-2-specific antibodies capable of binding to FcRn, FCGR2A/B and FCGR3A/B predominantly in males ( Fig. 2C and Supplementary Fig. 2 ). Although transfer ratios for SARS-CoV-2-specific antibodies were significantly higher for female fetuses than those of males, they were still lower than the expected 1.1-1.5 ratios often observed for other pathogens (47, 56, 57) .

SARS-CoV-2-specific functional antibodies were also transferred less efficiently, with a marked male-specific decrease in antibody-dependent complement deposition (ADCD)-inducing antibodies and antibodies that induce natural killer (NK) cell chemokine secretion (macrophage inflammatory protein-1b/MIP-1b)( Fig. 2E-F) .

In contrast to SARS-CoV-2-specific antibodies, efficient transfer of pertussis antigen pertactin (PTN) and the influenza hemagglutinin (HA) glycoprotein-specific titers ( Fig. 2C -D, Supplementary Fig. 3 ) and functions ( Fig. 2E -F) was observed across pregnancies with both female and male fetuses.

As transplacental passive humoral immune transfer from maternal to cord blood is dependent in part on maternal antibody titers (58), we assessed the influence of fetal sex on maternal anti-SARS-CoV-2 antibody titers. Maternal levels of SARS-CoV-2-specific IgG1 were significantly lower in mothers with a male fetus compared to a female fetus (Fig. 2G ). This effect was specific to anti-SARS-CoV-2 antibodies, with no significant impact of fetal sex on maternal anti-HA and PTN titers (Fig. 2H ). Similar results were observed for maternal IgG2, IgG3, and IgM ( Supplementary Fig. 4 ). Overall, these results suggest a reduced maternal SARS-CoV-2-specific humoral immune response in pregnancies with male fetuses. The reduced maternal antibody titers in mothers with male fetuses are consistent with prior studies demonstrating suppressed maternal proinflammatory responses in mothers with a male fetus relative to female fetus (13, 14) and the known direct correlation between pro-inflammatory response and increased antibody production in COVID-19 infection (59, 60) . For each SARS-CoV-2 antigen, significance was determined against the HA-specific activity using the matched SARS-CoV-2 + dyad. Kruskal-Wallis test followed by post-hoc analyses was performed to determine significance. # p < 0.01 compared to HA SARS-CoV-2 + of that sex, * p < 0.01 compared to indicated group. G. Bar graphs depicting Spike-, RBD-, S1-, S2-, and N-specific maternal blood IgG1 levels. Two-way ANOVA followed by post-hoc analyses was used to determine significance. There was a main effect of fetal sex on maternal IgG1 levels. Units are MFI: Mean Fluorescence Intensity. *p < 0.05. H. Bar graphs depicting HA-and PTN-specific maternal blood IgG1 levels. SARS-CoV-2 negative maternal status is shown in blue (female: open bars; male: shaded bars) and SARS-CoV-2 positive maternal status is shown in orange (female: open bars; male: shaded bars). Two-way ANOVA revealed no effect of fetal sex or maternal SARS-CoV-2 infection status. Units are MFI: Mean Fluorescence Intensity.

The transfer of maternal antibodies across the placenta is mediated by Fc receptors (36, 37) . The neonatal Fc receptor (FcRn) was considered the classical receptor mediating transplacental transfer of IgG (61) (62) ,

although other Fc receptors (FcI,II,III) are increasingly recognized as being expressed in the placenta and likely to play a role in transfer (36, 37) . Given the lower maternal antibody levels in pregnancies with a male fetus, we next aimed to probe the potential contribution of Fc-receptor expression to antibody-transfer differences across fetal sex. We observed sexually dimorphic expression of FCGRT, FCGR1, FCGR3A and Table 3 ). The gene and protein expression results suggest that maternal SARS-CoV-2 infection has a sexually dimorphic impact on placental Fcγ receptor expression, driven by an increase in overall expression and in FCR3/FcRn co-localization in male placentas.

Such increases may be compensatory for lower maternal titers of IgG in the setting of a male fetus, but still

were not able to restore normal placental transfer of humoral immunity to male fetuses. models. S1-specific IgG1 transfer was modeled because the most significant sex difference was noted in the transfer of this antibody (Fig. 2B) . Given that transfer of SARS-CoV-2 specific antibodies in fetuses of both sexes was less than the expected cord:maternal ratio of ≥1.1-1.5, there was no truly high or efficient transfer.

Ratio thresholds for distinguishing higher and lower transfer were therefore determined based on the natural distribution of the data. For female neonates, this ratio was 0.8, and for males, this ratio was 0.4 (reflective of more impaired transfer in males). To investigate whether multivariate analysis could identify gene signatures specific to relatively high or low transfer, we performed O-PLSDA separately on the female and male neonates ( Fig. 4A-D) . To avoid overfitting the O-PLSDA model, features were reduced to the 'optimal' set of nonredundant features using LASSO feature selection (63) . In both male and female pregnancies, high placental expression of FCGR3B was associated with lower IgG1 S1 transfer efficiency (Fig. 4) . Interestingly, higher placental IL10 expression was associated with higher IgG1 S1 transfer in female pregnancies, but lower transfer efficiency in male pregnancies (Fig. 4B,4D) . In male pregnancies, high expression of OAS1 was associated with higher transfer (Fig. 4D) . Overall, these O-PLSDA models support a systemic sexually dimorphic response that triggers distinct inflammatory cascades likely critical for driving different levels of antibody production in mothers, as well as Fc-receptor expression alterations aimed at compensating for these differences.

We also examined the sex-specific impacts of other disease and birth-related factors on placental ISG and Fc-receptor expression, and placental antibody transfer. Using linear regression we did not observe significant impact of time since infection or disease severity on male or female placental expression of any ISGs, pro-inflammatory cytokines, Fc receptors, or IgG transfer ( Supplementary Fig. 6 ). Additionally, though both male and female neonates born to SARS-CoV-2 positive mothers had statistically significantly lower birthweight compared to sex-matched controls, birthweights were in the normal range for both groups (Table 1) and birthweight did not significantly impact IgG antibody transfer in linear regression models ( Supplementary   Fig 6) . Similarly, we did not observe significant associations between antibody transfer and days from infection or gestational age at delivery for either male or female neonates ( Supplementary Fig. 6 ). In summary, disease severity, time since infection, neonatal birthweight, and gestational age at delivery do not appear to confound our earlier findings related to sexually dimorphic gene expression and antibody transfer. 

Our results demonstrate the impact of fetal sex on the maternal and placental immune response to SARS-CoV-2, and the potential consequences for neonatal antibody-mediated immunity. We show that maternal SARS-CoV-2 infection is associated with sexually dimorphic expression of interferon stimulated genes and Fc receptors involved in placental transfer of maternal antibodies, with significant upregulation of ISGs and Fc receptors in SARS-CoV-2-exposed males. Male fetal sex was associated with reduced maternal SARS-CoV-2-specific IgG titers, and despite significant compensatory upregulation of placental Fc receptors, SARS-CoV-2-specific placental antibody transfer to the male fetus was reduced. Crosstalk between innate immunity (ISGs) and antibody adapters (FcRn/Fcγ) has been demonstrated to play a key role in optimizing tissue-specific immune responses against unfamiliar pathogens (64, 65) . While Type I and III interferon responses may help protect the placenta from SARS-CoV-2 infection, the associated male-specific upregulation of placental Fc receptors was unable to overcome the deficit in SARS-CoV-2-specific antibody transfer from mother to fetus.

Epidemiologic data point to a persistent male bias in the development and severity of COVID-19 disease in adults, children, and infants (6, 8, 9, 68, 69) . Male COVID-19 patients are three times as likely to require admission to intensive care units and have higher odds of death than females (70) . This male-biased vulnerability to maternal SARS-CoV-2 infection is consistent with a male-biased risk of mortality and morbidity across the perinatal period in general (1) (2) (3) . Our findings of sexually dimorphic placental innate immune responses to infection, coupled with sex differences in transfer of maternal humoral immunity, may reveal broader vulnerabilities contributing to higher morbidity and mortality in male infants.

Although the impact of fetal sex is not consistently evaluated in studies of placental function (71), sexspecific alterations in the placental transcriptome have been described in both normal and pathologic pregnancies (72) (73) (74) (75) . Sex differences in the placental immune response to prenatal infections and other immune stressors have been described in human and animal models (32, (76) (77) (78) (79) , but have not been examined in SARS-CoV-2 infection. Here we report that maternal SARS-CoV-2 infection induces a sexually dimorphic placental anti-viral innate immune response, with significant upregulation of ISGs in male, but not female, placentas.

Male-specific stimulation of placental ISGs following SARS-CoV-2 exposure is consistent with the heightened male immune responses reported in SARS-CoV-2-infected adult and pediatric cohorts (5, 6, 8-10, 26, 80) .

Interestingly, although we do not see evidence of placental, maternal blood, or cord blood SARS-CoV-2

infection (46) , and the majority of maternal infections represent mild or moderate disease, there is still evidence of altered placental gene expression and an anti-viral response in the placentas of male pregnancies. This indicates that even a mild maternal infection has the potential to affect the placenta and fetus.

Innate immune sensing of SARS-CoV-2 involves the activation of type I and type III interferons and upregulation of ISGs in target cells (81) . Given the relative paucity of SARS-CoV-2 placental infection (46) in comparison to other pandemic infections such as Zika (82), the increased ISG production and upregulated IL10 expression in exposed male placentas may be a protective mechanism to prevent direct placental infection and pathology. Indeed, high IFN levels during pregnancy have proven protective against placental HSV infection Due to their immature immune system, newborns rely on the passive transplacental transfer of maternal antibodies for initial protection against infectious pathogens (36, 39, 86) . While previous reports in adults have noted sex differences in production of SARS-CoV-2-specific antibodies (26, 87) , this is the first report of sex- FCGR3A/B we observed in male SARS-CoV-2-exposed placentas may therefore be a response to significantly increased IFN signaling in exposed male placentas. Hofbauer cells, tissue-resident macrophages of the placenta, express FcRI, II and III (41) . The male-specific Hofbauer cell hyperplasia in placentas exposed to maternal SARS-CoV-2 infection could contribute to increased placental FCGR1/FCGR3 expression in males.

Importantly, given the known role of placental Fc receptors in facilitating transplacental antibody transfer to the fetus, the male-specific upregulation of these receptors could be a compensatory response for the lower maternal SARS-CoV-2-specific antibody titers we describe in pregnancies with a male fetus. 

Sample collection protocols have been described in a previous publication (102) and are described in detail in the Supplementary Materials and Methods.

A multiplexed Luminex assay was used to determine relative titer of antigen-specific isotypes, subclasses, and FcR binding, as previously described (45) . Detailed methodology is available in the Supplementary Materials and Methods.

Fetal side biopsies (0.5 cubic centimeter per biopsy) were collected immediately after delivery. Biopsies were taken from two separate locations at least 4 cm from the cord insertion avoiding surface vasculature, edges, and areas of gross pathology. Fetal membranes were dissected from the fetal and maternal surfaces, respectively.

Biopsies were serially washed in DPBS, submerged in 5 volumes of RNAlater® (Invitrogen), and stored at least 24 hours at 4°C. Excess RNAlater® was removed by blotting on Kimwipes, and biopsies were subdivided into 50 mg segments, placed into cryovials, flash frozen in liquid nitrogen and stored at -80°C. For histopathological examination, placentas were fixed in formalin, weighed, examined grossly, and sectioned/stained as described below.

Placental tissue was placed in Trizol (100 uL/10 mg) and homogenized using a TissueTearor. Chloroform extraction was performed using an Rneasy Mini Kit (Qiagen), and cDNA synthesis was performed using iScript TM cDNA Synthesis Kit (Bio-Rad) according to manufacturer instructions, as detailed in the Supplemental materials and methods.

Placental tissue was placed in RIPA Lysis and Extraction Buffer (ThermoFisher Scientific #89901) containing

Halt Protease and Phosphatase Inhibitor Cocktail (ThermoFisher Scientific #78443) and homogenized using a

TissueTearor. Resulting mixture was centrifuged at 10,000 rpm for 10 min at 4°C and supernatant was kept for protein quantification. Protein was quantified using Pierce BCA Protein Assay Kit (ThermoFisher Scientific #23225). and quantified using Image Lab Software (Bio-Rad). Data is presented as volume of bands for protein of interest relative to the volume of bands contained in the total protein stain-free image.

For co-labeling immunofluoresence (IF) experiments, placenta tissue sections were prepared as previously described (47) . Detailed methodology is available in the Supplementary Materials and Methods.

All multivariate analyses were performed using R (version 4.0.0) and are detailed in the Supplementary Materials and Methods.

Statistical analyses were performed using GraphPad Prism 9 and using the 'stats' package in R (Version 4.0.0). 

Sample collection protocols have been described in a previous publication (102) and are summarized below.

Blood from pregnant women was collected at delivery by venipuncture into EDTA tubes. Umbilical cord blood was collected immediately after delivery. The umbilical cord was wiped clean and blood was drawn directly from the vein using a syringe and transferred to EDTA vacutainer tubes. Blood was centrifuged at 1000g for 10 min at room temperature. Plasma was aliquoted into cryogenic vials and stored at -80°C.

A multiplexed Luminex assay was used to determine relative titer of antigen-specific isotypes, subclasses, and

FcR binding, as previously described (45) . The following antigens were used in this assay: SARS-CoV-2 RBD 

Placental tissue was placed in Trizol (100 uL/10 mg) and homogenized using a TissueTearor. The resulting suspension was then centrifuged at 12,000 x g for 10 min after which the pellet was discarded. Chloroform was added to supernatant at a ratio of 100 uL chloroform/50 mg tissue. Tubes were shaken vigorously for 15 seconds, allowed to stand at room temperature for 10 min, and then centrifuged at 12,000 x g for 15 min. The aqueous phase was collected and the remainder of the RNA extraction procedure was performed using an All genes of interest were probed using gene expression assays with a dye of FAM-MGB, and YWHAZ was assessed using gene expression assays with a dye of VIC_PL. Two separate biopsies were each run in technical duplicate, and the average of biological replicates were then used to obtain final reported 2 -ddCt values.

Placental tissue was placed in RIPA Lysis and Extraction Buffer (ThermoFisher Scientific #89901) containing

Halt Protease and Phosphatase Inhibitor Cocktail (ThermoFisher Scientific #78443) and homogenized using a

TissueTearor. The resulting mixture was centrifuged at 10,000 rpm for 10 min at 4 degrees C and supernatant was kept for protein quantification. Protein was quantified using Pierce BCA Protein Assay Kit (ThermoFisher Scientific #23225). CellProfiler software (PMID:29969450) was used to quantify CD16/FcRn, CD32/FcRn, and CD64/FcRn colocalization as well as their respective intensities. Briefly, RGB pictures were converted to gray and placental vilii selected to avoid measuring background. Following background removal, the pictures were filtered using the function CorrectIlluminationCalculate and aligned to evaluate colocalization. Finally, CD16, CD32 or CD64

and FcRn intensities in the placental vilii previously delimitated to quantify colocalization.

CellProlifer software was similarly used to quantify immunohistochemistry for ACE2 and CD163. Following isolation of each dye compound (DAB and Hematoxylin), the placental vilii were manually isolated and the mean intensity of DAB signal quantified.

All multivariate analyses were performed using R (version 4.0.0). Multivariate analyses included qPCR and Luminex antibody measurements. Missing data measurements were imputed using the k-nearest neighbor algorithm. Features were then centered and scaled to unit variance. Orthogonal partial least square discrimination analysis (O-PLSDA) was performed to classify data based on relative antibody transfer. Prior to building the O-PLSDA models, LASSO feature regularization and variable selection was performed, resulting in a reduced set of features that were consistently included in at least 80 out of 100 LASSO models. O-PLSDA models were built using the R 'ropls' Bioconductor package (orthI =1; PredI=1). Models were validated by evaluating the mean accuracy score after 100 trials of 5-fold CV. Accuracy scores for analogous models with permutated labels and random features were also reported for comparison.

Statistical tests used and statistical significance are reported in the Figure Legends . Statistical analyses were performed using GraphPad Prism 9 and R (version 4.0.0). Significant differences in participant characteristics were evaluated using Kruskal-Wallis tests for continuous variables and chi-square or Fisher's exact tests for categorical variables. Gene expression measurements, immunoblot measurements, and immunohistochemistry staining comparing maternal SARS-CoV-2 exposure status and fetal sex were evaluated by 2-way analysis of variance (2-way ANOVA) with Bonferroni's post-hoc analysis. Kruskal-Wallis test followed by Dunn's posthoc test was used to determine significant differences between transfer ratios. Wilcoxon matched-pairs signed rank test was performed to determine significant differences between paired maternal-cord blood samples. All linear regression models were built in R (version 4.0.0) using the 'stats' package. False discovery rate (FDR) multiple comparisons correction was performed for Supplemental Fig. 6 using a corrected p-value of 0.05 as the cutoff for significance. n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a Table 2. 2-way ANOVA analysis of inflammatory cytokine and interferon stimulated gene expression. Two-way ANOVA followed by Bonferroni's post-hoc analyses (when interaction term was significant) were performed to determine significance. All main and interaction effects for genes of interest are represented for both male and female placentas in addition to all post-hoc analyses performed. Significant effects are indicated by bolded statistics. N/A: not applicable, indicates post-hoc testing not performed due to lack of significant interaction term. n/a n/a n/a n/a

Gender variations in neonatal and early infant mortality in India and Pakistan: a secondary analysis from the Global Network Maternal Newborn Health Registry

The evolution of infant mortality inequality in the United States

Why is infant mortality higher in boys than in girls? A new hypothesis based on preconception environment and evidence from a large sample of twins

National Institute of Child Health and Human Development Neonatal Research Network, Intensive care for extreme prematurity--moving beyond gestational age

Multisystem Inflammatory Syndrome in Children in the United States

COVID-19-Associated Multisystem Inflammatory Syndrome in Children -United States

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

COVID-NET Surveillance Team, Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 -COVID-NET, 14 States

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses

The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: A meta-analysis and systematic review

Sex differences in pediatric infectious diseases

Sex differences in immune responses

The impact of female fetal sex on preeclampsia and the maternal immune milieu

Fetal sex is associated with maternal stimulated cytokine production, but not serum cytokine levels, in human pregnancy

Shared and Distinct Functions of Type I and Type III Interferons

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Rapid generation of a mouse model for Middle East respiratory syndrome

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Dysregulation of immune response in patients with COVID-19 in Wuhan

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Sex differences in immune responses that underlie COVID-19 disease outcomes

Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection

What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses

Type III Interferons in Antiviral Defenses at Barrier Surfaces

Type I interferons instigate fetal demise after Zika virus infection

Contributions of maternal and fetal antiviral immunity in congenital disease

Females Are Not Just 'Protected' Males": Sex-Specific Vulnerabilities in Placenta and Brain after Prenatal Immune Disruption

Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring

Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival

Maternal obesity and sex-specific differences in placental pathology

Transfer of maternal immunity and programming of the newborn immune system

Alter, Fc Glycan-Mediated Regulation of Placental Antibody Transfer

Placental antibody transfer: influence of maternal HIV infection and placental malaria

Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators

Noncanonical placental Fc receptors: What is their role in modulating transplacental transfer of maternal IgG?

Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women

Human placental Fc receptors and the transmission of antibodies from mother to fetus

Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya

Fowkes, P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission

Alter, Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load

Alter, Compromised SARS-CoV-2-specific placental antibody transfer

Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity

Protective and Pathogenic Effects of Interferon Signaling During Pregnancy

Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection

CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection

SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

The Elusive Role of Placental Macrophages: The Hofbauer Cell

SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers

SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta

Placental gene expression and antibody levels of mother-neonate pairs reveal an enhanced risk for inflammation in a helminth endemic country

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

Transplacental transfer of measles and total IgG

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

COVID-19-neutralizing antibodies predict disease severity and survival

FcRn: the neonatal Fc receptor comes of age

Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and preterm newborns

Feature selection using lasso, VU Amsterdam Research Paper in Business Analytics

Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways

Fcgamma receptors as regulators of immune responses

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Placental transporter localization and expression in the Human: the importance of species, sex, and gestational age differences †

Imprinted and X-linked non-coding RNAs as potential regulators of human placental function

Integrative transcriptome metaanalysis reveals widespread sex-biased gene expression at the human fetal-maternal interface

Diet-induced obesity alters the maternal metabolome and early placenta transcriptome and decreases placenta vascularity in the mouse

Sexually Dimorphic Crosstalk at the Maternal-Fetal Interface

Sex-specific maternofetal innate immune responses triggered by group B Streptococci

Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment

The Alabama Preterm Birth Study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks

Sex modifies placental gene expression in response to metabolic and inflammatory stress

Considering how biological sex impacts immune responses and COVID-19 outcomes

Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies

High interferon alpha levels in placenta, maternal, and cord blood suggest a protective effect against intrauterine herpes simplex virus infection

Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero

Antiviral Inflammation during Early Pregnancy Reduces Placental and Fetal Growth Trajectories

Ontogeny of early life immunity

Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions

High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody

Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea

Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants

Social stress in pregnant squirrel monkeys (Saimiri boliviensis peruviensis) differentially affects placental transfer of maternal antibody to male and female infants

Effect of Prepregnancy Pertussis Vaccination in Young Infants

SARS-CoV-2 serology levels in pregnant women and their neonates

Unidirectional transport of IgG by neonatal Fc receptor in human thyrocytes varies across different IgG subclasses

Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults

Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3

Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG

Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus

A-C) qPCR analyses of fetal male or fetal female expression of (A) TNF, (B) IL6, and (C) CCL7 in placental biopsies from SARS-CoV-2 negative (blue) or SARS-CoV-2 positive (orange) pregnancies. Two-way ANOVA followed by post-hoc analyses were performed to determine significance. Expression levels shown are relative to reference gene YWHAZ

SARS-CoV-2 infected mothers with male fetuses demonstrate reduced placental transfer of SARS-CoV-2 antibodies compared to those with female fetuses. Dot plots showing relative Spike-, RBD-, S1-, S2-, and N-specific maternal blood (M) and cord blood (C) titers of (A) IgG2, (B), IgG3, (C) FcRn, (D) FCGR2A, (E) FCGR2B, (F) FCGR3A, and (G) FCGR3B. Females are shown in light orange while males are shown in dark orange with black border. Wilcoxon matched pairs signed rank test was performed to determine significance

Supplementary Figure 3. Maternal and cord blood titers of HA and PTN in SARS-CoV-2 infected and noninfected mothers

C) titers of (A) IgG1, (B) IgG2, (C) IgG3, (D) FcRn, (E) FCGR2A, (F) FCGR2B, (G) FCGR3A, and (H) FCGR3B. SARS-CoV-2 -females are shown in light blue, SARS-CoV-2 + females are shown in light orange, SARS-CoV-2 -males are shown in dark blue, and SARS-CoV-2 + males are shown in dark orange. Y-axis units for all plots are PBS-corrected mean fluorescence intensity (MFI). Wilcoxon matched-pairs signed rank test was performed to determine significance

SARS-CoV-2 infected mothers with male fetuses have lower plasma levels of SARS-CoV-2-specific antibodies

Female neonates of mothers with SARS-CoV-2 are shown as white bars with an orange border while male neonates are shown as orange shaded bars with orange border. Two-way ANOVA followed by post-hoc analyses were performed to determine significance. There was a main effect of fetal/neonatal sex on maternal IgG1 levels

Plots showing levels of IgG2 against HA and PTN in maternal plasma from either SARS-CoV-2 negative or SARS-CoV-2 positive mothers. Females born to SARS-CoV-2 -mothers are shown as white bars with blue border, females born to SARS-CoV-2 + mothers are shown as white bars with orange border. Males born to SARS-CoV-2 -mothers are shown as shaded blue bars with blue border, and males born to SARS-CoV-2 + mothers are shown as orange shaded bars with orange border

Plots showing maternal Spike-, RBD-, S1-, S2-, and N-specific maternal blood IgG3 levels. Two-way ANOVA followed by post-hoc analyses were performed to determine significance

Plots showing levels of IgG3 against HA and PTN in maternal plasma from either SARS-CoV-2 negative or SARS-CoV-2 positive pregnancies. Two-way ANOVA revealed no significant effect of fetal sex

Plots showing maternal Spike-, RBD-, S1-, S2-, and N-specific maternal blood IgM3 levels. Two-way ANOVA followed by post-hoc analyses were performed to determine significance. There was a main effect of fetal sex on maternal IgM levels

Plots showing levels of IgM against HA and PTN in maternal plasma from either SARS-CoV-2 negative or SARS-CoV-2 positive pregnancies. Two-way ANOVA revealed no significant effect of fetal sex

None of the regression models had statistical significance after FDR multiple comparisons correction using a corrected p-value of 0.05 as the cutoff. (C) Linear regression models were performed on female (top) and male (bottom) neonates separately to examine the effect of birthweight on placental transfer of S1-specific IgG1 (no significant effect). (D) Linear regression models were performed on pregnancies with a female fetus (top) and male fetus (bottom) separately to examine the effect of days since maternal infection on transplacental transfer of S1-specific IgG1 (no significant effect). (E) Linear regression models were performed on female (top) and male (bottom) neonates separately to examine the effect of gestational age at delivery on placental transfer of S1-specific IgG1 (no significant effect). Table 3 . 2-way ANOVA analysis of Fc receptor gene expression, immunoblots, and immunohistochemistry. Two-way ANOVA followed by Bonferroni's post-hoc analyses (when interaction term was significant) were performed to determine significance. All main and interaction effects for genes and proteins of interest are represented for both male and female placentas in addition to all post-hoc analyses performed. Significant effects are indicated by bolded statistics. N/A: not applicable, indicates post-hoc testing not performed due to lack of significant interaction term. ThermoFisher Scientific Assay ID, Gene symbol, and color dye for each gene expression assay used.